For a disease in which a variety of microbial triggers are recognized, our findings are consistent with the hypothesis that upregulation of EBI2 is important in the pathogenesis of disease in a subset of CFS/ME patients. The gene discussed is GPR183; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.